Case Counts

The Infectious Diseases & Outbreaks Division monitors the incidence and prevalence of communicable, zoonotic, and environmentally-related human diseases. This table summarizes cases reported over the last five years, as well as the cases reported year-to-date this year and last year. 

 

Cases Reported Year-to-Date*

Totals by Year Reported

Condition

2019

2018

% Change

2018

2017

2016

2015

2014

Acute Flaccid Myelitis

0

0^

--

4^

--

--

--

--

Anthrax

0

0^

--

0^

0

0

0

0

Arboviral Diseases (includes West Nile virus, Zika virus, and other Arboviral diseases)

2

0

--

32

67

60^

10^

23^

Babesiosis

0

0

--

1

1

0

2

1

Botulism

0

0

--

0

0

1

1

0

Brucellosis

0

0

--

1

0

0

2

0

Campylobacteriosis

9

10

-10.0%

780

790

692

589^

255

Cholera

0

0

--

0

0

0

0

0

Cryptosporidiosis

0

1

-100.0%

150

189

334

261

147

Dengue

0

0

--

3

0

5

3^

3

E. coli, shiga toxin-producing (includes O157:H7)

1

1^

0.0%

127^

31

39

40

41^

Ehrlichiosis/Anaplasmosis

0

0

--

24

17

21

18

19

Giardiasis

4

0

--

217

191

234

188

182

Hansen's Disease (Leprosy)

0

0

--

0

1

1

1

0

Hantavirus Pulmonary Syndrome

0

0^

--

0^

--

--

--

--

Hemolytic uremic syndrome (HUS)

1

0

--

2

0

6

3

1

Influenza-associated non-pediatric mortality

0

7^

-100.0%

110^

--

--

--

--

Influenza-associated pediatric mortality

0

0

--

2

1

0

1

1

Legionellosis

0

0

--

75

66

63

59

62

Leptospirosis

0

0

--

1

0

0

0

1

Listeriosis

0

1

-100.0%

11

5

8

5

9

Lyme disease

1

0

--

32

39^

38

25

17

Malaria

0

0

--

8

8

11

11

14^

Novel Influenza A virus infection

0

0

--

0

0

0

0

0^

Paratyphoid Fever

0^

0^

--

6^

3

9

0

0

Plague

0

0

--

0

0

0

0

0

Psittacosis

0

0

--

0

0

0

0

0

Q fever

0

0

--

3

0

1

0

2

Rabies, animal

0

0

--

55

51

77

83

78

Rabies, human

0

0

--

0

0

0

0

0

Salmonellosis

9

12^

-25.0%

1161^

1130^

1276

1151

1165

Severe Acute Respiratory Syndrome-associated Coronavirus (SARS-CoV)

0

0

--

0

0

0

0

0

Shigellosis

5

8

-37.5%

315

247^

239

680

516

Spotted Fever Rickettsiosis

4

2

100.0%

662

671

453

288

220

Toxic Shock Syndrome (non-streptococcal)

0

0^

--

0^

--

--

--

--

Trichinellosis (Trichinosis)

0

0

--

0

0

0

0

0^

Tularemia

0

0

--

0

1^

1

0

0

Typhoid fever

0^

0

--

1

1

0

0

2

VISA (Staphylococcus aureus, vancomycin-intermediate)

0

0

--

1

4

3

2

2

VRSA (Staphylococcus aureus, vancomycin-resistant)

0

0

--

0

0

0

0

0

Vibriosis (non-Cholera)

0

2

-100.0%

38

26^

31

19

20

Yellow Fever

0^

0

--

0

0

0

0

0

Other Investigations

0

0

--

0

0

0

0

27

Total

36

44

-18.2%

3540

2097

3543

2840

2730

NOTE: Counts include finalized investigations among Alabama residents as of January 11, 2019. The Other investigations category includes a variety of conditions or events that have been investigated, but are not reportable in Alabama or do not fall into any other category (e.g., Histoplasmosis, Streptococcal toxic-shock syndrome, Yersiniosis, etc.). To see case counts for conditions investigated by other divisions, please see the following websites: Tuberculosis, Immunizations, Sexually Transmitted Diseases, and HIV/AIDS.

*Through MMWR Week 1 (week ending January 5, 2019), as compared to the same time period in the previous calendar year.

^The case definition was updated this year for this condition.

 



Page last updated: January 11, 2019